Automate Your Wheel Strategy on CAH
With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CAH
- Rev/Share 984.4958
- Book/Share -11.4748
- PB -16.6831
- Debt/Equity -3.1372
- CurrentRatio 0.957
- ROIC 0.1177
- MktCap 47949579123.0
- FreeCF/Share 18.7059
- PFCF 10.7703
- PE 30.1133
- Debt/Assets 0.1635
- DivYield 0.0101
- ROE -0.55
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CAH | Citigroup | Neutral | Buy | -- | -- | Jan. 9, 2026 |
| Initiation | CAH | Barclays | -- | Overweight | -- | $243 | Dec. 9, 2025 |
| Upgrade | CAH | Wells Fargo | Equal Weight | Overweight | -- | $179 | June 3, 2025 |
| Upgrade | CAH | Jefferies | Hold | Buy | $140 | $150 | Feb. 5, 2025 |
| Upgrade | CAH | TD Cowen | Hold | Buy | $130 | $144 | Jan. 8, 2025 |
| Upgrade | CAH | Evercore ISI | In-line | Outperform | -- | $140 | Jan. 7, 2025 |
| Upgrade | CAH | BofA Securities | Neutral | Buy | $132 | $145 | Jan. 6, 2025 |
| Upgrade | CAH | Wells Fargo | Underweight | Equal Weight | $101 | $127 | Dec. 13, 2024 |
| Resumed | CAH | Mizuho | -- | Outperform | -- | $139 | Dec. 4, 2024 |
News
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
3 MedTech Stocks That Crushed the S&P 500 Over the Past Year
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.
Read More
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Best Dividend Aristocrats For January 2026
Published: December 31, 2025 by: Seeking Alpha
Sentiment: Positive
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
Read More
4 Stocks With Solid Interest Coverage to Navigate the 2026 Market
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
AMZN, CAH, LRN and EAT stand out with strong interest coverage ratios to help weather 2026's shifting market tides.
Read More
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Published: December 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.
Read More
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal Health (CAH) closed the most recent trading day at $202.95, moving +1.93% from the previous trading session.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: December 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Published: December 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Published: December 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Read More
4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026
Published: December 01, 2025 by: Zacks Investment Research
Sentiment: Positive
High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.
Read More
Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Cardinal (CAH) Upgraded to Buy: Here's Why
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
Published: November 21, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
6 Healthcare Stocks With Strong Upward Momentum
Published: November 18, 2025 by: Benzinga
Sentiment: Positive
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.
Read More
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript
Published: November 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. ( CAH ) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Matt Sims - Vice President of Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good morning, everybody. Thanks for joining us.
Read More
4 Value Stocks With Strong Interest Coverage as Markets Rebound
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
As Wall Street rebounds on hopes of a shutdown resolution, investors turn to value picks like LTH, CAH, MCK and FLS with strong interest coverage ratios.
Read More
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
About Cardinal Health, Inc. (CAH)
- IPO Date 1983-08-04
- Website https://www.cardinalhealth.com
- Industry Medical - Distribution
- CEO Jason Hollar
- Employees 47922